Clinical Trial Update: Safety/Efficacy of Bromfenac Ophthalmic Solution for Ocular Inflammation and Pain Associated With Cataract Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating the safety and efficacy of bromfenac ophthalmic solution for reducing ocular inflammation and pain after cataract surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Inflammation
• Postoperative Pain

Drugs mentioned

• Bromfenac Ophthalmic Solution (bromfenac sodium)

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Pain, Inflammation | Phase 3 | Status: COMPLETED